Novonesis (Novozymes) B ADR NVZMY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $62.16
- Day Range
- $61.86–63.27
- 52-Week Range
- $49.90–75.27
- Bid/Ask
- $52.99 / $88.36
- Shares Outstanding
- 466.47M
- Market Cap
- $29.19B
- Volume/Avg
- 21,860 / 24,628
Key Statistics
- Price/Earnings (Normalized)
- 27.46
- Price/Sales
- 5.79
- Dividend Yield (Trailing)
- 1.62%
- Dividend Yield (Forward)
- 1.62%
- Dividend Payment Schedule
- Apr, Sep
- Total Yield
- 1.62%
Company Profile
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs more than 11,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Stock Style Box
- Large Growth
- Total Number of Employees
- 11,641
- Website
- https://www.novonesis.com
Competitors
Valuation
|
Metric
|
NVZMY
|
GIVN
|
DSFIR
|
|---|---|---|---|
Price/Earnings (Normalized) | 27.46 | 31.09 | 12.28 |
Price/Book Value | 2.28 | 7.05 | 1.33 |
Price/Sales | 5.79 | 4.21 | 3.38 |
Price/Cash Flow | 19.72 | 21.39 | 17.45 |
Price/Earnings
NVZMY
GIVN
DSFIR
Financial Strength
|
Metric
|
NVZMY
|
GIVN
|
DSFIR
|
|---|---|---|---|
Quick Ratio | 1.04 | 0.70 | 0.82 |
Current Ratio | 1.74 | 1.29 | 1.75 |
Interest Coverage | 16.80 | 10.87 | — |
Quick Ratio
NVZMY
GIVN
DSFIR
Profitability
|
Metric
|
NVZMY
|
GIVN
|
DSFIR
|
|---|---|---|---|
Return on Assets (Normalized) | 5.52% | 9.24% | — |
Return on Equity (Normalized) | 8.34% | 24.97% | — |
Return on Invested Capital (Normalized) | 6.76% | 12.86% | — |
Return on Assets
NVZMY
GIVN
DSFIR
Specialty Chemicals Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Linde PLC
LIN
| LOCK|>tP#>@% | LOCK|!pw | $221B | |||
| Sherwin-Williams Co
SHW
| LOCK|<Q#<?n#? | LOCK|<X^ | $78B | |||
| Ecolab Inc
ECL
| LOCK|!jJHg^# | LOCK|<V< | $77B | |||
| Air Products and Chemicals Inc
APD
| LOCK|#w%>?h& | LOCK|tJz | $62B | |||
| PPG Industries Inc
PPG
| LOCK|S%!LPDk | LOCK|NP!p^ | $23B | |||
| International Flavors & Fragrances Inc
IFF
| LOCK|>hXFc<n | LOCK|pN<% | $21B | |||
| LyondellBasell Industries NV Class A
LYB
| LOCK|wvqVX> | LOCK|WwR$% | $19B | |||
| Sociedad Quimica Y Minera De Chile SA ADR
SQM
| LOCK|X>h>Kj? | LOCK|G<&bh | $18B | |||
| DuPont de Nemours Inc
DD
| LOCK|<c!!$Y | LOCK|JF@xH | $18B | |||
| Albemarle Corp
ALB
| LOCK|@hVQ>G? | LOCK|<S>w | $12B |
United States